SelectION

San Diego, United States

SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases

$5.4M raised

Sep 2025

Series C

Top Investors

SDL VenturesGlobal Source Ventures

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has SelectION raised?

SelectION has raised $5.4M in total funding. The most recent round was Series C. The last funding was announced in September 2025.

Who are SelectION's investors?

SelectION's investors include SDL Ventures, Global Source Ventures.

Where is SelectION headquartered?

SelectION is headquartered in San Diego, United States.

What does SelectION do?

SelectION is a clinical-stage biopharmaceutical company developing novel peptide therapies for autoimmune diseases

What stage is SelectION at?

SelectION is at the Series C stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 15, 2025.

MLA

"SelectION — Funding & Investors." VCBacked, September 15, 2025, https://www.vcbacked.co/company/selection. Accessed June 17, 2026.

APA

VCBacked. (2025). SelectION — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/selection

Wikipedia (cite web)

{{cite web |title=SelectION — Funding & Investors |url=https://www.vcbacked.co/company/selection |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 15, 2025.